Skip to content
Targeting Drug-Resistant Bacteria with an Ancient Enemy episode artwork

Nov 9, 2017 20 min

Targeting Drug-Resistant Bacteria with an Ancient Enemy

from The Bio Report Hosted by Levine Media Group

The growing problem of bacterial resistance to antibiotics represents a significant public health threat. That’s been made worse by the dearth of new therapies that have come to market. AmpliPhi Biosciences is developing bacteriophages, viruses that infect and kill bacteria, to provide a way to target drug-resistant bugs. We spoke to Paul Grint, CEO of AmpliPhi about the health need, AmpliPhi’s approach, and why harnessing these natural killers of bacteria may provide a promising source of new therapeutics.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Targeting Drug-Resistant Bacteria with an Ancient Enemy

0:00 20:28

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of The Bio Report?

This episode is 20 minutes long.

When was this The Bio Report episode published?

This episode was published on November 9, 2017.

Can I download this The Bio Report episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.